Latest evidence on immune checkpoint inhibitors in metastatic colorectal cancer: A 2022 update.

Boukouris, Aristeidis E; Theochari, Maria; Stefanou, Dimitra; Papalambros, Alexandros; Felekouras, Evangelos; Gogas, Helen; Ziogas, Dimitrios C

Boukouris, Aristeidis E; Theochari, Maria; Stefanou, Dimitra; Papalambros, Alexandros; Felekouras, Evangelos; Gogas, Helen; Ziogas, Dimitrios C.

Afiliación

Boukouris AE; First Department of Internal Medicine, Korgialeneion-Benakeion General Hospital, Athens, Greece. Electronic address: arisbouk@gmail.com.
Theochari M; First Department of Medicine, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece. Electronic address: mtheochari@gmail.com.
Stefanou D; First Department of Medicine, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece. Electronic address: dimitroulastef@hotmail.com.
Papalambros A; First Department of Surgery, Laikon General Hospital, School of Medicine, National Kapodistrian University of Athens, Athens, Greece. Electronic address: a_papalampros@hotmail.com.
Felekouras E; First Department of Surgery, Laikon General Hospital, School of Medicine, National Kapodistrian University of Athens, Athens, Greece. Electronic address: felek@med.uoa.gr.
Gogas H; First Department of Medicine, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece. Electronic address: helgogas@gmail.com.
Ziogas DC; First Department of Medicine, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece. Electronic address: ziogasdc@gmail.com.

Crit Rev Oncol Hematol ; 173: 103663, 2022 May.

Article en En | MEDLINE | ID: mdl-35351582

Asunto(s)

Neoplasias del Colon; Neoplasias Colorrectales; Neoplasias del Recto; Anticuerpos Monoclonales Humanizados; Neoplasias del Colon/tratamiento farmacológico; Neoplasias Colorrectales/tratamiento farmacológico; Neoplasias Colorrectales/genética; Reparación de la Incompatibilidad de ADN; Humanos; Inhibidores de Puntos de Control Inmunológico/farmacología; Inhibidores de Puntos de Control Inmunológico/uso terapéutico; Ipilimumab/uso terapéutico; Inestabilidad de Microsatélites; Nivolumab/uso terapéutico; Microambiente Tumoral

Palabras clave

Anti-CTLA4; Anti-PD-1/PD-L1; Deficient MMR/microsatellite instability-high (dMMR/MSI-H); Immune-checkpoint inhibitors; Immunotherapy; Metastatic colorectal cancer; Mismatch repair-proficient/microsatellite stable (pMMR/MSS)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias del Recto / Neoplasias Colorrectales / Neoplasias del Colon Límite: Humans Idioma: En Revista: Crit Rev Oncol Hematol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google